E

Evaxion Biotech A/S

72 employees

Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Antigen Discovery
Neo Epitope Discovery
Immunotherapy
Artificial Intelligence
AI-Immunology
Immuno-Oncology
Infectious Diseases
Vaccines
Bioinformatics
Immunoinformatics

Date founded

2008

Funding rounds raised

Total raised

$40M

from 3 investors over 3 rounds

E

Evaxion Biotech A/S raised $20M on August 1, 2023

Investors: Negma Group

E

Evaxion Biotech A/S raised undisclosed on September 6, 2022

Investors: National Institutes of Health

E

Evaxion Biotech A/S raised $40M on June 7, 2022

Investors: Lincoln Park Capital, LLC

FAQ